The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Pima County sheriff no stranger to controversy as criticism in Nancy Guthrie case ramps up
US military launches deadly strike on drug-trafficking vessel in the Caribbean, leaving 3 dead
Liability or useful foil? Trump takes center stage in Susan Collins reelection fight
Schumer’s ‘E. coli’ burger photo resurfaces after another Dem’s grilling skills get torched: ‘What is that?’
Rubio steps into Munich spotlight as Trump leans on him to carry Vance’s populist message abroad
Trump ousts judge-installed prosecutor; constitutional expert says Article II leaves no doubt
Texas Dem Senate primary fractures over race rhetoric as ‘mediocre’ jab, ‘oppressor’ remarks ignite backlash
Mexican Restaurant Owner Under Fire for Offering ICE Agents Free Meals Fires Back at Leftists: ‘They Need to Look for Jesus’
Reporter’s Notebook: Bondi’s binder strategy turns House hearing into political firestorm
CEO Resigns After His Disturbing Jeffrey Epstein Email Comes to Light: ‘I Loved the Torture Video’
The Numbers Are In: Disney’s ‘Snow White’ Remake Was a Bigger Disaster Than Anyone Imagined
Noem backs SAVE America Act, slams ‘radical left’ opposition to voter IDs and proof of citizenship
Fox News True Crime Newsletter: Ransom deadline passes, key evidence emerges in Nancy Guthrie case
California middle school assistant principal nabbed in child sex sting
Don Lemon pleads not guilty to charges for storming Minnesota church
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Pima County sheriff no stranger to controversy as criticism in Nancy Guthrie case ramps up
US military launches deadly strike on drug-trafficking vessel in the Caribbean, leaving 3 dead
Liability or useful foil? Trump takes center stage in Susan Collins reelection fight
Schumer’s ‘E. coli’ burger photo resurfaces after another Dem’s grilling skills get torched: ‘What is that?’
Rubio steps into Munich spotlight as Trump leans on him to carry Vance’s populist message abroad
Trump ousts judge-installed prosecutor; constitutional expert says Article II leaves no doubt
Texas Dem Senate primary fractures over race rhetoric as ‘mediocre’ jab, ‘oppressor’ remarks ignite backlash
Mexican Restaurant Owner Under Fire for Offering ICE Agents Free Meals Fires Back at Leftists: ‘They Need to Look for Jesus’
Reporter’s Notebook: Bondi’s binder strategy turns House hearing into political firestorm
CEO Resigns After His Disturbing Jeffrey Epstein Email Comes to Light: ‘I Loved the Torture Video’
The Numbers Are In: Disney’s ‘Snow White’ Remake Was a Bigger Disaster Than Anyone Imagined
Noem backs SAVE America Act, slams ‘radical left’ opposition to voter IDs and proof of citizenship
Fox News True Crime Newsletter: Ransom deadline passes, key evidence emerges in Nancy Guthrie case
California middle school assistant principal nabbed in child sex sting
Don Lemon pleads not guilty to charges for storming Minnesota church
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
